statistiche ricercatore

Continente	#
NA - Nord America	1.511
EU - Europa	544
AS - Asia	408
SA - Sud America	35
AF - Africa	21
Continente sconosciuto - Info sul continente non disponibili	15
Totale	2.534

Nazione	#
US - Stati Uniti d'America	1.474
CN - Cina	171
RU - Federazione Russa	116
SG - Singapore	114
DE - Germania	105
PL - Polonia	63
IT - Italia	59
GB - Regno Unito	51
FR - Francia	45
HK - Hong Kong	38
BR - Brasile	31
CA - Canada	30
UA - Ucraina	30
SE - Svezia	25
VN - Vietnam	22
FI - Finlandia	15
ZA - Sudafrica	14
KR - Corea	13
TR - Turchia	13
BE - Belgio	10
IE - Irlanda	7
JP - Giappone	7
BD - Bangladesh	6
IN - India	5
ES - Italia	4
KE - Kenya	4
JO - Giordania	3
LT - Lituania	3
PK - Pakistan	3
AE - Emirati Arabi Uniti	2
DZ - Algeria	2
JM - Giamaica	2
MX - Messico	2
NL - Olanda	2
RO - Romania	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
VE - Venezuela	2
AM - Armenia	1
AZ - Azerbaigian	1
EC - Ecuador	1
EU - Europa	1
GD - Grenada	1
GR - Grecia	1
GT - Guatemala	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
KH - Cambogia	1
LV - Lettonia	1
MD - Moldavia	1
MY - Malesia	1
PH - Filippine	1
PR - Porto Rico	1
RS - Serbia	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	2.520

Nome	#
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands	300
Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones	293
Synthesis and biological evaluation of indazolo[4,3-bc][1,5]naphthyridines (10-aza-pyrazolo[3,4,5-kl]acridines): a new class of antitumor agents.	286
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery	281
Rational Design, Synthesis and Biological Evaluation of Bis(pyrimido[5,6,1-de]acridines) and Bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as New Anticancer Agents	260
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands	238
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs	237
Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs	226
Molecular modeling studies on the human neuropeptide S receptor and its antagonists.	224
The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines. Implications for overcoming multidrug resistance towards leukaemia K562/DOX cells	189
Totale	2.534

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	118	0	28	1	6	8	11	9	6	11	17	5	16
2022/2023	176	19	12	11	36	13	27	0	9	27	6	10	6
2023/2024	116	18	3	8	5	5	22	2	6	10	1	3	33
2024/2025	300	10	7	20	13	5	25	38	74	24	15	18	51
2025/2026	495	24	26	48	96	67	41	79	39	14	34	21	6
2026/2027	43	35	8	0	0	0	0	0	0	0	0	0	0
Totale													2.534